Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?
作者： Michael Simons
DOI: 10.1016/J.JACC.2005.06.008
关键词:
摘要: Type II diabetes mellitus is a complex disease with protean clinical manifestations characterized, at its core, by tissue resistance to insulin. This fundamental abnormality leads increased circulating insulin levels and concomitant hyperglycemia that, in turn, are thought be responsible for
onlinejacc.org
elsevier.com参考文章(17)
Y. Duraisamy, M. Slevin, N. Smith, J. Bailey, J. Zweit, C. Smith, N. Ahmed, J. Gaffney, Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: Possible relevance to wound healing in diabetes Angiogenesis. ,vol. 4, pp. 277- 288 ,(2001) , 10.1023/A:1016068917266
Karin E Bornfeldt, How does diabetes accelerate atherosclerotic plaque rupture and arterial occlusion Frontiers in Bioscience. ,vol. 8, ,(2003) , 10.2741/1190
Robert D. Galiano, Oren M. Tepper, Catherine R. Pelo, Kirit A. Bhatt, Matthew Callaghan, Nicholas Bastidas, Stuart Bunting, Hope G. Steinmetz, Geoffrey C. Gurtner, Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. American Journal of Pathology. ,vol. 164, pp. 1935- 1947 ,(2004) , 10.1016/S0002-9440(10)63754-6
Michael Simons, J. Anthony Ware, Therapeutic angiogenesis in cardiovascular disease Nature Reviews Drug Discovery. ,vol. 2, pp. 863- 871 ,(2003) , 10.1038/NRD1226
Jennifer Wilkinson-Berka, Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Current Pharmaceutical Design. ,vol. 10, pp. 3331- 3348 ,(2004) , 10.2174/1381612043383142
Radia Tamarat, Jean-Sébastien Silvestre, Maya Huijberts, Joelle Benessiano, Teni G. Ebrahimian, Micheline Duriez, Marie-Paule Wautier, Jean Luc Wautier, Bernard I. Lévy, Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 8555- 8560 ,(2003) , 10.1073/PNAS.1236929100
Ferdinando Carlo Sasso, Daniele Torella, Ornella Carbonara, Georgina M. Ellison, Michele Torella, Michelangelo Scardone, Claudio Marra, Rodolfo Nasti, Raffaele Marfella, Domenico Cozzolino, Ciro Indolfi, Maurizio Cotrufo, Roberto Torella, Teresa Salvatore, Increased Vascular Endothelial Growth Factor Expression But Impaired Vascular Endothelial Growth Factor Receptor Signaling in the Myocardium of Type 2 Diabetic Patients With Chronic Coronary Heart Disease Journal of the American College of Cardiology. ,vol. 46, pp. 827- 834 ,(2005) , 10.1016/J.JACC.2005.06.007
Alan Chait, Karin E. Bornfeldt, Lisa R. Tannock, Farah Kramer, Matthias G. von Herrath, Fredrik Johansson, Najib Lamharzi, Catherine B. Renard, Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions Journal of Clinical Investigation. ,vol. 114, pp. 659- 668 ,(2004) , 10.1172/JCI17867
Oren M. Tepper, Robert D. Galiano, Jennifer M. Capla, Christoph Kalka, Paul J. Gagne, Glen R. Jacobowitz, Jamie P. Levine, Geoffrey C. Gurtner, Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures Circulation. ,vol. 106, pp. 2781- 2786 ,(2002) , 10.1161/01.CIR.0000039526.42991.93
J Waltenberger, Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovascular Research. ,vol. 49, pp. 554- 560 ,(2001) , 10.1016/S0008-6363(00)00228-5